You can buy or sell FMS and other stocks, options, ETFs, and crypto commission-free!
Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. Read More It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Bad Homburg, Hessen
52 Week High
52 Week Low
Markets InsiderMar 14
FDA Grants Breakthrough Device Designation to Fresenius Medical Care North America's Software for Fluid Management During Hemodialysis
WALTHAM, Mass., March 14, 2019 /PRNewswire/ -- Fresenius Medical Care North America's Renal Therapies Group, the leading provider of kidney care products, announced today that the U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to its computer-assisted ultrafiltration (UF) control software currently in development to improve fluid management during hemodialysis and personalize treatments. The software will be designed to work with newer Fresenius Medical Care hemodialysis...
Yahoo FinanceMar 14
Should Value Investors Pick Fresenius Medical (FMS) Stock?
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Fresenius Medical Care AG & Co. KGaA FMS stock into this equation and ...
Markets InsiderMar 11
DGAP-CMS: Fresenius Medical Care AG & Co. KGaA: Release of a capital market information
DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Notification pursuant to Article 5(1)(a) of Regulation (EU) No 596/2014 and Article 2(1) of Delegated Regulation (EU) No 2016/1052 Fresenius Medical Care AG & Co. KGaA: Release of a capital market information 11.03.2019 / 18:37 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Fresenius Medical C...
Available May 2, Pre-Market